SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-16-015959
Filing Date
2016-05-09
Accepted
2016-05-09 16:55:42
Documents
57
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q arna-2016331x10q.htm 10-Q 779886
2 EXHIBIT 31.1 exhibit31133116.htm EX-31.1 11878
3 EXHIBIT 32.1 exhibit32133116.htm EX-32.1 7280
  Complete submission text file 0001628280-16-015959.txt   3807750

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT arna-20160331.xml EX-101.INS 623517
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arna-20160331.xsd EX-101.SCH 40755
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arna-20160331_cal.xml EX-101.CAL 53166
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arna-20160331_def.xml EX-101.DEF 186446
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arna-20160331_lab.xml EX-101.LAB 449380
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arna-20160331_pre.xml EX-101.PRE 273458
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31161 | Film No.: 161632435
SIC: 2834 Pharmaceutical Preparations